Clinical Trial Update: Open Label Extension Study of NCT06221852 [NA]

View source ↗

Summary

Open-label extension study NCT06221852 is currently enrolling by invitation. The sponsor is McLean Hospital and the study targets Bipolar I Disorder, Schizoaffe…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bipolar Disorder
• Psychosis
• Schizoaffective Disorder

Snippet

Sponsor: Mclean Hospital | Conditions: Bipolar I Disorder, Schizoaffective Disorder | NA | Status: ENROLLING_BY_INVITATION